Hims vs SnagRx: Which GLP-1 Provider Is Better?
Short answer: Hims scores higher on our rubric, 5.9/10 against 4.5/10. Full reasoning, pricing and the cases where the other one wins are below.
Hims beats SnagRx overall, scoring 5.9/10 vs 4.5/10. Published pricing is not a like-for-like monthly comparison: Hims is $188 first month, then $298/mo; SnagRx is published $99/mo; total not verified. Choose Hims for men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors. Choose SnagRx for price-first buyers comfortable prepaying a multi-month plan from the company that operates embody, our most-converted partner, and who will verify the consult-fee clause in the terms before checkout.
A side-by-side look at Hims and SnagRx to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hims
#40 of 54The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy, Ozempic, Foundayo, Zepbound and Mounjaro paths and has since exited compounded semaglutide for new retail patients. The advertised medication floor is $149, but the required Weight Loss Membership adds $39 in month one and $149/month after that, so the all-in floor is $188 initially and $298 ongoing before any product- or dose-specific increase. Its parent still reports offering access to compounded GLP-1 medications on a limited scale (Q2 2026 results, filed with the SEC August 10, 2026). Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 2.9 stars across 9,185 reviews (checked 2026-09-03), below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 29%, the highest 1-star rate in our table, clustered around subscription and billing complaints.
Visit HimsSnagRx
#50 of 54SnagRx is a cash-pay compounded GLP-1 storefront operated by Modern Metabolic Medicine, Inc., the same company behind Embody and RodeoMeds. Its semaglutide and tirzepatide pages publish a full four-tier grid above the buy button: semaglutide at $99/mo month-to-month, $89 on three months, $79 on six and $69 on a twelve-month plan billed $828 upfront, and tirzepatide at $149, $139, $129 and $119, with multi-month plans billed once and auto-renewing for the same length. The homepage leads the 12-month rates against struck-through comparison prices of $299 and $399. Read the refund policy before the price: payment is final and non-refundable at the moment of purchase, and multi-month plans are non-refundable in whole and in part, so the grid is a committed spend rather than a monthly bill. The terms also refer to non-refundable medical consult fees and warn the final charge may vary by medication and pharmacy. Shipping is free at a stated 1-2 days. Four partner pharmacies are named in the footer with addresses, and the terms allow a prescription to be transferred among them. The site launched in January 2026 and its Trustpilot profile carries 2 reviews at 3.8 stars (checked 2026-09-03).
Visit SnagRx| Feature | Hims | SnagRx |
|---|---|---|
| Our Score | 5.9/10 | 4.5/10 |
| Headline Price | $188 first month, then $298/mo | published $99/mo; total not verified |
| Medication Type | Brand | Compounded |
| Insurance Accepted | No | No |
| Best For | Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors | Price-first buyers comfortable prepaying a multi-month plan from the company that operates Embody, our most-converted partner, and who will verify the consult-fee clause in the terms before checkout |
| Watch out for | Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable. | Almost no independent review record. The Trustpilot profile, claimed in June 2026, carries 2 reviews at 3.8, so the '125k+ Happy Customers' banner on the homepage cannot be corroborated anywhere (checked 2026-09-03) |
| Ranking | #40 | #50 |
| Get started | Visit Hims | Visit SnagRx |
Pros & Cons Compared
Hims
Pros
- +Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
- +2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
- +Medication starts at $149/mo for Wegovy pill, Foundayo, and Ozempic pill; Wegovy or Ozempic pens start at $199 and Zepbound at $299. The required membership makes the lowest all-in path $188 in month one and $298/mo ongoing, and exact product or dose can cost more.
- +Polished app and web experience, among the best user interfaces in men's telehealth.
- +9,185 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.
Cons
- −Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.
- −Trustpilot rating is 2.9 stars across 9,185 reviews (checked 2026-09-03), below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
- −29% of Trustpilot reviews are 1-star (checked 2026-09-03), the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
- −Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
- −Hims says GLP-1s are not yet available in all 50 states and does not publish which states are excluded, so confirm your own state before you pay the first membership fee.
- −Hims states in its own terms that it is not a HIPAA covered entity, and that anything you send it outside diagnosis, treatment or prescription fulfilment is governed only by its privacy policy. The pending FTC complaint concerns health information shared with advertising platforms, so read that disclosure before you fill in the intake.
- −The $149 GLP-1 figures are medication-only. A required Weight Loss Membership costs $39 in month one and $149/mo ongoing, so a $149 medication path totals at least $188 initially and $298/mo after that.
- −Cash-pay only, Hims does not bill insurance, so an insured buyer may do better on a copay.
- −Generic high-volume support, large patient base means less personalized attention than smaller competitors.
SnagRx
Pros
- +A published plan grid with locked flat pricing across doses, on the product pages rather than buried in the terms: semaglutide at $99, $89, $79 and $69/mo across one, three, six and twelve months, and tirzepatide at $149, $139, $129 and $119; a consult-fee clause and a price-variance clause in the terms remain the unresolved costs
- +Names four partner pharmacies in its footer with full street addresses and phone numbers, Red Rock Compounding, Health Warehouse, Precision Medicine and Triad Rx, which most competitors do not do
- +Free 1-2 day shipping with a stated one-day turnaround from intake to a written prescription
- +The site markets a locked medication rate with no monthly membership and publishes a separate refund policy; its terms still leave a possible medical consult fee unresolved
- +States service in all 50 states plus Washington D.C. in its terms, and names the two carve-outs on the homepage: no service in Louisiana, and Nebraska limited to patients 19 and over
Cons
- −Almost no independent review record. The Trustpilot profile, claimed in June 2026, carries 2 reviews at 3.8, so the '125k+ Happy Customers' banner on the homepage cannot be corroborated anywhere (checked 2026-09-03)
- −The homepage leads the 12-month rate ($69/mo, billed $828 once) under a countdown timer that re-seeds on each visit instead of counting down to a dated deadline, while the month-to-month rate is $99
- −'Cancel Anytime' appears three times on the homepage, but the refund policy requires a cancellation at least 72 hours before the next billing date to stop that charge, and cancelling only halts future billing. It returns nothing you have already paid
- −'No Hidden Fees' is contradicted by the terms, which refer to medical consult fees that are not refundable
- −Payment is final and non-refundable at the moment of purchase, before a clinician has read your intake, and multi-month plans are sold as a single indivisible purchase that is non-refundable in whole and in part. The one exception is a provider ruling you medically ineligible, and even then the value of services already rendered is deducted
- −No individual clinician is named. SnagRx says in a homepage FAQ that it has a medical director who is a practising physician, and its footer names OpenLoop Health as the treating network, but no provider name, licence number, lab requirement or video-visit detail is published
- −Shares its operating entity with Embody and RodeoMeds. Neither SnagRx nor Embody discloses the relationship on its own site, so a shopper comparing them would not know they are one company
- −Cash-pay only, no insurance billing and no prior-authorisation help
Our Verdict
Hims edges out SnagRx with a score of 5.9/10 vs 4.5/10. Published pricing is not a like-for-like monthly comparison: Hims is $188 first month, then $298/mo; SnagRx is published $99/mo; total not verified.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Hims and SnagRx.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Hims and Luvo Healthfrom $249/mo
- Compare Hims and HealthRXfrom $99/mo
- Compare Hims and MyStart Healthfrom $299/mo
- Compare SnagRx and Zealthyfrom $286/mo
- Compare SnagRx and Care Bare Rxfrom $199/mo
- Compare SnagRx and Calibratepublished $199/mo; total not verified
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Hims legit, with the verification evidence behind each answer.
Our pick of these two: Hims · 5.9/10